MENUNews Archive
Date: 11/08/2022
The death rate for women with metastatic breast cancer is linked to the number of chronic health conditions they have, according to a study by the University of Michigan in partnership with the Kaiser Permanente Southern California Department of Research & Evaluation.
Date: 10/25/2022
In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a large, longitudinal analysis found Veterans Health Administration (VA) medical centers with lower prostate screening rates had higher rates of metastatic prostate cancer cases in subsequent years than centers with higher screening rates.
Date: 10/24/2022
A new study, presented at the annual ASTRO meeting, finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.
Date: 10/13/2022
An international team of researchers led by the University of Michigan Rogel Cancer Center received a collaborative grant from the National Cancer Institute with a goal of bringing new insights into leiomyosarcoma, a rare form of cancer that seemingly originates in smooth muscle. The grant, worth $12.3 million, is through the NCI’s SPORE, or Specialized Program of Research Excellence, which funds collaborative, interdisciplinary translational cancer research.
Date: 10/12/2022
Rogel Cancer Center faculty and trainees will lead 30 presentations, posters and moderated sessions at the American Society of Radiation Oncology annual meeting. This year’s meeting will be held in-person, virtually and on-demand.
Date: 10/05/2022
Friends, faculty and staff of the Rogel Cancer Center gathered amidst a rainbow of lights, ribbons and balloons on Sept. 23 to raise money for cancer research.
Date: 10/03/2022
Menthol cigarettes are designed to make it easier to start smoking and harder to quit. In Michigan, 40% of callers to the state’s Tobacco Quitline are menthol users. Now, a new partnership between the University of Michigan Rogel Cancer Center and the Quitline will develop and test strategies to help menthol users kick the habit.
Date: 09/29/2022
Researchers at the University of Michigan Rogel Cancer Center have developed a computational platform that can predict new and specific metabolic targets in ovarian cancer, suggesting opportunities to develop personalized therapies for patients that are informed by the genetic makeup of their tumors.
Date: 09/22/2022
Daniel Chang, M.D., was named chair of the Department of Radiation Oncology at Michigan Medicine. The University of Michigan Board of Regents approved the appointment at its Sept. 22 meeting. Chang, who is currently the Sue and Bob McCollum Professor of Radiation Oncology at Stanford University, will begin at U-M on Oct. 1.
Date: 09/20/2022
Rogel researchers have developed a new mathematical technique to begin to understand how a cell’s nucleus is organized. The technique, tested on several types of cells, revealed what the researchers termed self-sustaining transcription clusters, a subset of proteins that play a key role in maintaining cell identity. They hope this understanding will expose vulnerabilities that can be targeted to reprogram a cell to stop cancer or other diseases.